890339-03-4Relevant academic research and scientific papers
PHARMACEUTICAL COMPOSITIONS CONTAINING QUINAZOLINE DERIVATIVES FOR TREATING AS SEROTONIN RECEPTOR ANTAGONIST
-
, (2009/07/02)
The present invention relates to a pharmaceutical composition containing one or more quinazoline compounds as an active ingredient, which has antagonistic activity against serotonin 5-HT3A and is effective for the prevention and treatment of ce
Novel T-type calcium channel blockers: Dioxoquinazoline carboxamide derivatives
Jo, Mi Na,Seo, Hee Jeong,Kim, Yoonji,Seo, Seon Hee,Rhim, Hyewhon,Cho, Yong Seo,Cha, Joo Hwan,Koh, Hun Yeong,Choo, Hyunah,Pae, Ae Nim
, p. 365 - 373 (2008/02/05)
T-type calcium channel is one of therapeutic targets for the treatment of cardiovascular diseases and neuropathic pains. Since the withdrawal of mibefradil, a T-type calcium channel blocker, there have been a lot of efforts to develop T-type calcium chann
